Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-826-4
CAS number: 127-19-5
Groups of 8 male and 8 female ChR-CD rats were exposed for 1 h to
time weighted concentrations of: 3.4 (measured range 2.4-4.8), 5.8
(3.8-22.9), or 8.8 (6.6-13.0) mg/L. The test substance was
syringe-driven into a spraying system nebulizer. The post exposure
observation period was 14 days. No mortality was found in males at any
exposure concentration. Females were more susceptible than males. At 8.8
mg/L 4 out of 8 females died within 48 h but no deaths were seen at the
low and mid dose level. No clinical signs were recorded except
hyperactivity in females on day 3-7 after exposure. Initial reduction in
body weight was detected in males at >= 5.8 mg/L and in females at 8.8
mg/L. Conclusion: The LC50 (1 h) in female rats was estimated to be 8.8
mg/L; no mortality was seen in male rats at the time weighted average of
8.8 mg/L. The LC50(1 hour) of DMAC was determined to be 8.8 mg/L
in female rats. Female rats were more susceptible than males.
However, in this study conspicuous variations in dose levels were
obvious and exclusive exposure to vapour (as mentioned by the authors)
was not clear.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again